“Antidepressant use is not associated with an increased risk of suicide, according to a recent US study.
The findings, published in the American Journal of Psychiatry, are in contrast to previous reports suggesting that use of antidepressants called selective serotonin reuptake inhibitors (SSRIs) may increase suicidal tendencies.
Dr Arif Khan, from the Northwest Clinic Research Center in Bellevue, Washington, and colleagues reached their conclusions after reviewing suicide data from US Food and Drug Administration summary reports. ”
As you know, I have taken a strong stand against what I have considered the irresponsible attacks on the medications for supposedly promoting suicide (or violence), which have often led to high-profile lawsuits with national press coverage. Among other consequences, patients suffering from antidepressant-responsive conditions become more reluctant to take the most suitable medications for their distress.
The use of the medications is in fact associated with suicide and other adverse outcomes. However, it is not the fault of the drugs but rather the conditions of modern medical treatment, with inadequate supervision of the potentially suicidal patient by prescribers who are often not trained well enough and do not have enough time to sit with their antidepressant patients. As I often rail against, this is partly the fault of pharmaceutical companies’ targeting doctors outside the psychiatric field to do the prescribing themselves without referring their patients to specialized mental health practitioners, persuading them how easy the SSRIs are to use, which is a recipe for disaster. Some patients on antidepressants become suicidal as they improve; others because they do not improve; and still others as a result of the agitating side effect of these medications can sometimes cause, akathisia. Still others are at risk because a psychosis concomitant with the depression goes unrecognized or untreated, and some may have altogether different unrecognized psychiatric or neuropsychiatric disorders mistakenly assumed to be antidepressant-responsive.
The chances of any of these being recognized and addressed appropriately are tremendously diminished if the patient is not under the care of a practitoner who has the time to sit with a patient, the skill to create an alliance that will allow the patient to reveal their inner life with frankness, diagnostic expertise and sophistication in assessing and managing psychiatric medication tolerability and efficacy, as well as the very specific proficiency to assess suicidality.